Dr. Eran Duzman, MD

Dr. Duzman practices at Efraim Duzman M.d., INC in Irvine, California.

Dr. Duzman's NPI, 1174548903, was assigned on July 13, 2006. Dr. Duzman graduated from New York Medical College in 1993. Dr. Duzman's California license number on file is G84694.

Dr. Duzman's primary practice is Efraim Duzman M.d., INC, at 4605 Barranca Pkwy Suite 100 Suite 100, Irvine, CA 92604-1726. The practice phone is (949) 733-2002.

Dr. Duzman's primary practice is Efraim Duzman M.d., INC in Irvine, California. Dmand AI also links Dr. Duzman to 1 medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Duzman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Duzman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Duzman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Duzman's licenses on file in 2 states: California and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Duzman treats.

CMS data shows 1,197 Medicare services from Dr. Duzman across 12 procedure codes in 2024, for 367 Medicare patients. Medicare paid $107,941 for them.

CMS counts 367 Medicare patients who saw Dr. Duzman in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Duzman's median patient age at 72, with 56% women.

In 2024, Dr. Duzman wrote 1,544 Medicare Part D claims for 443 patients. 32% of them were for generic drugs. CMS names the drug for 1,434 of them, across 18 drugs with 11 or more claims each, at $429,867 in total drug cost. In 2023, CMS named 1,523 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Duzman for performance year 2024, reported individually. Dr. Duzman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 62 procedures of cataract surgery by Dr. Duzman, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Duzman. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Levobunolol. Dr. Duzman has published most often in Am J Ophthalmol. Dr. Duzman's most frequent co-authors are Efraim Duzman, MD, Patricia K. Lafleur, MD and Michael A. Kass, MD.

CMS Open Payments shows 247 general payments to Dr. Duzman from 29 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Allergan Inc. paid the most, $40,343. It also lists 14 research payments totaling $18,868 from 2016 to 2025, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Duzman, most recently CMS Stage 1 EHR in 2013.

Dr. Duzman graduated from New York Medical College in 1993. Dr. Duzman is a member of AAO.

Dr. Duzman is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.